Legend Total Current Liabilities from 2010 to 2024
| LEGN Stock | USD 45.30 0.88 1.98% |
Total Current Liabilities | First Reported 2010-12-31 | Previous Quarter 216.4 M | Current Value 203.5 M | Quarterly Volatility 90 M |
Check Legend BiotechCorp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Legend main balance sheet or income statement drivers, such as Tax Provision of 268.9 K, Interest Expense of 22.9 M or Selling General Administrative of 112.1 M, as well as many exotic indicators such as Price To Sales Ratio of 70.16, Dividend Yield of 0.0 or PTB Ratio of 8.04. Legend financial statements analysis is a perfect complement when working with Legend BiotechCorp Valuation or Volatility modules.
Legend | Total Current Liabilities |
Latest Legend BiotechCorp's Total Current Liabilities Growth Pattern
Below is the plot of the Total Current Liabilities of Legend BiotechCorp over the last few years. Total Current Liabilities is an item on Legend BiotechCorp balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Legend BiotechCorp are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. Legend BiotechCorp's Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Legend BiotechCorp's overall financial position and show how it may be relating to other accounts over time.
| Total Current Liabilities | 10 Years Trend |
|
Total Current Liabilities |
| Timeline |
Legend Total Current Liabilities Regression Statistics
| Arithmetic Mean | 124,200,997 | |
| Geometric Mean | 97,229,671 | |
| Coefficient Of Variation | 72.48 | |
| Mean Deviation | 76,884,264 | |
| Median | 52,122,000 | |
| Standard Deviation | 90,015,806 | |
| Sample Variance | 8102.8T | |
| Range | 245.7M | |
| R-Value | 0.85 | |
| Mean Square Error | 2471.5T | |
| R-Squared | 0.72 | |
| Significance | 0.000069 | |
| Slope | 17,041,006 | |
| Total Sum of Squares | 113439.8T |
Legend Total Current Liabilities History
About Legend BiotechCorp Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Legend BiotechCorp income statement, its balance sheet, and the statement of cash flows. Legend BiotechCorp investors use historical funamental indicators, such as Legend BiotechCorp's Total Current Liabilities, to determine how well the company is positioned to perform in the future. Although Legend BiotechCorp investors may use each financial statement separately, they are all related. The changes in Legend BiotechCorp's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Legend BiotechCorp's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Legend BiotechCorp Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Legend BiotechCorp. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Total Current Liabilities | 216.4 M | 203.5 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Legend BiotechCorp Correlation against competitors. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for Legend Stock analysis
When running Legend BiotechCorp's price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |
Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.94) | Revenue Per Share 1.619 | Quarterly Revenue Growth 1.876 | Return On Assets (0.17) | Return On Equity (0.52) |
The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend BiotechCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.